BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33551350)

  • 21. Elevated Serum α-Fetoprotein is Associated with Abbreviated Survival for Patients with Fibrolamellar Hepatocellular Carcinoma Who Undergo a Curative Resection.
    McDonald JD; Gupta S; Shindorf ML; Gamble LA; Ruff SM; Drake J; Heller T; Wan JY; Dickson PV; Glazer ES; Davis JL; Deneve JL; Hernandez JM
    Ann Surg Oncol; 2020 Jun; 27(6):1900-1905. PubMed ID: 31925595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of an extremely high preoperative alpha-fetoprotein value (>4,000 ng/mL) for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma.
    Sasaki K; Matsuda M; Ohkura Y; Kawamura Y; Inoue M; Hashimoto M; Ikeda K; Kumada H; Watanabe G
    Surgery; 2015 Feb; 157(2):223-30. PubMed ID: 25616938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Could patients who underwent hepatic resection due to hepatocellular carcinoma with high alpha-fetoprotein be monitored for recurrence by alpha-fetoprotein level?].
    Shin WY; Suh KS; Kim T; Jeon YM; Yi NJ; Lee KU
    Korean J Hepatol; 2010 Jun; 16(2):168-75. PubMed ID: 20606501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
    Blank S; Wang Q; Fiel MI; Luan W; Kim KW; Kadri H; Mandeli J; Hiotis SP
    Ann Surg Oncol; 2014 Mar; 21(3):986-94. PubMed ID: 24232510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
    Lin CY; Lin CC; Wang CC; Chen CL; Hu TH; Hung CH; Huang PY; Tsai MC
    World J Surg; 2020 Jan; 44(1):247-257. PubMed ID: 31559485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis.
    Tian BW; Yan LJ; Ding ZN; Liu H; Meng GX; Xue JS; Han CL; Dong ZR; Hong JG; Chen ZQ; Wang DX; Li T
    Expert Rev Gastroenterol Hepatol; 2023 Jan; 17(1):73-83. PubMed ID: 36476076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.
    Zhou PY; Yang CP; Tang Z; Yi Y; Liu WR; Tian MX; Huang JL; Gan W; Jiang XF; Liu G; Wang H; Tao CY; Fang Y; Qu WF; Zhou C; Guan RY; Sun BY; Zhou YF; Song SS; Ding ZB; Peng YF; Dai Z; Zhou J; Fan J; Gong GZ; Shi YH; Qiu SJ
    Aging (Albany NY); 2019 Dec; 11(23):11111-11123. PubMed ID: 31829979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in serum alpha fetoprotein in patients with recurrent hepatocellular carcinoma following hepatectomy.
    Liu G; Wang K; Li J; Xia Y; Lu L; Wan X; Yan Z; Shi L; Lau WY; Wu M; Shen F
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1405-11. PubMed ID: 25801981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.
    Zhang XF; Lai EC; Kang XY; Qian HH; Zhou YM; Shi LH; Shen F; Yang YF; Zhang Y; Lau WY; Wu MC; Yin ZF
    Ann Surg Oncol; 2011 Aug; 18(8):2218-23. PubMed ID: 21336512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein.
    Santambrogio R; Opocher E; Costa M; Barabino M; Zuin M; Bertolini E; De Filippi F; Bruno S
    Ann Surg Oncol; 2012 Feb; 19(2):426-34. PubMed ID: 21732145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
    Jeng KS; Sheen IS; Tsai YC
    Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
    Huang J; Liu FC; Li L; Zhou WP; Jiang BG; Pan ZY
    Cancer Med; 2020 Apr; 9(8):2791-2802. PubMed ID: 32096346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma.
    Nobuoka D; Kato Y; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kinoshita T; Nakatsura T
    Oncol Rep; 2010 Aug; 24(2):521-8. PubMed ID: 20596642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Lee JS; Chon YE; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kang W; Choi MS; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW; Kim HY; Kim TH; Yoo K; Ha Y; Kim MN; Lee JH; Hwang SG; Kim SS; Cho HJ; Cheong JY; Cho SW; Park SH; Heo NY; Hong YM; Yoon KT; Cho M; Park JG; Kang MK; Park SY; Kweon YO; Tak WY; Jang SY; Sinn DH; Kim SU;
    Yonsei Med J; 2021 Jan; 62(1):12-20. PubMed ID: 33381930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.
    Chon YE; Choi GH; Lee MH; Kim SU; Kim DY; Ahn SH; Kim KS; Choi JS; Han KH; Chon CY; Park JY
    Int J Cancer; 2012 Nov; 131(10):2332-41. PubMed ID: 22362471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection.
    Shirabe K; Takenaka K; Gion T; Shimada M; Fujiwara Y; Sugimachi K
    J Surg Oncol; 1997 Feb; 64(2):143-6. PubMed ID: 9047252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy.
    Sun LY; Cen WJ; Tang WT; Deng L; Wang F; Ji XM; Yang JJ; Zhang RJ; Zhang XH; Du ZM
    Dis Markers; 2022; 2022():7640560. PubMed ID: 35059044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.